Kangmei Pharma | 600518 - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Avita Medical AUD 3.3M 166K 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Genomma Lab Internacional MXN 1.56B 25.42M 2026-06
Hypermarcas BRL 807.21M 51.73M 2026-03
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Jiangsu Hengrui CNY 1.02B 68.56M 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Moderna USD 93M 862M 2026-06
Organon & Co USD 711M 34M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Sh Fosun Pharma CNY 5.22B 154.71M 2026-06
Viatris USD 2.3B 59.5M 2026-06
Wuxi Apptec CNY 7.15B 983.35M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03
Zz Pientze Pharmaceu CNY 1.17B 418.33M 2026-06